Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma - Trial NCT05894369
Access comprehensive clinical trial information for NCT05894369 through Pure Global AI's free database. This phase not specified trial is sponsored by Renmin Hospital of Wuhan University and is currently Recruiting. The study focuses on Esophageal Cancer. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Renmin Hospital of Wuhan University
Timeline & Enrollment
N/A
May 04, 2023
Dec 30, 2024
Primary Outcome
Tumor diameter
Summary
To evaluate the predictive value and mechanism of inflammatory factors in peripheral blood on
 the prognosis of patients, and to explore the influencing factors of inflammation and tumor
 microenvironment on the efficacy of neoadjuvant chemotherapy combined with immunotherapy for
 esophageal cancer. To explore the predictors of neoadjuvant therapy in patients with
 esophageal squamous cell carcinoma.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05894369
Non-Device Trial